NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report) rose 6% during mid-day trading on Thursday . The stock traded as high as $3.11 and last traded at $3.09. Approximately 1,143 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 9,252 shares. The stock had previously closed at $2.92.
NeurAxis Price Performance
The firm has a 50-day simple moving average of $3.08 and a 200 day simple moving average of $3.10. The company has a market capitalization of $20.57 million and a PE ratio of -0.83.
NeurAxis (NASDAQ:NRXS – Get Free Report) last announced its earnings results on Friday, August 9th. The company reported ($0.42) EPS for the quarter. The company had revenue of $0.61 million during the quarter.
About NeurAxis
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Featured Stories
- Five stocks we like better than NeurAxis
- How to invest in marijuana stocks in 7 steps
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Canadian Penny Stocks: Can They Make You Rich?
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- How to Invest in the FAANG Stocks
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
